- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
TAKHZYRO - - 1x2ml
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B06AC05 | BioTech | Lanadelumab - 300mg/2ml | 10626 | 141720/1 | TAKHZYRO | 1x2ml | Injectable solution | SC | Abela Frères S.A.L. | Catalent Indiana, LLC | USA | 1,204,227,927 L.L | 2.44 | E2 | Shire Pharmaceuticals Ireland Limited | Ireland | 2/5/2024 | 0 |